Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study on the Safety of the Postbiotic Lactobacillus LB (Lactéol®) in Immuocompromised Pediatric Patients With Diarrhoeal Disease Treated at the Federico Gómez Children's Hospital of Mexico.

NCT07758933 is registered in ClinicalTrials.gov with Hospital Infantil de Mexico Federico Gomez as lead sponsor.

NCT NCT07758933
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07758933 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study on the Safety of the Postbiotic Lactobacillus LB (Lactéol®) in Immuocompromised Pediatric Patients With Diarrhoeal Disease Treated at the Federico Gómez Children's Hospital of Mexico.
Lead sponsor
Hospital Infantil de Mexico Federico Gomez
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
July 13, 2026
Completion date
December 15, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diarrhea